{
    "clinical_study": {
        "@rank": "92507", 
        "arm_group": {
            "arm_group_label": "Lysine Chloride", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if administration of supplemental chloride in the\n      form of lysine chloride to patients with congestive heart failure will affect their\n      neurohormonal profile as well as response to diuretics."
        }, 
        "brief_title": "A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure", 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "detailed_description": {
            "textblock": "This prospective pilot \"pre-post\" study was designed to determine if supplementation of\n      sodium free chloride ion as a lysine chloride to patients with heart failure could improve\n      parameters of neurohormonal status and diuretic responsiveness. Volunteers will receive\n      Lysine Chloride 7 grams three times daily for three days. At baseline and then again post\n      lysine chloride patients will undergo sampling of venous blood for determination of\n      neurohormonal parameters in addition to formal diuretic responsiveness testing."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u226518 years\n\n          -  Fluency in English\n\n          -  Heart failure requiring loop diuretic therapy\n\n          -  Loop diuretic dose \u2265 80mg/day furosemide equivalents\n\n          -  Stable volume status and diuretic requirement as assessed by treating physician\n\n        Exclusion Criteria:\n\n          -  Unstable heart failure\n\n          -  renal replacement therapy or an estimated GFR < 30 ml/min/1.73m2\n\n          -  Significant bladder dysfunction\n\n          -  History of hepatic failure\n\n          -  Pregnancy\n\n          -  History of hyperinsulinemia/hyperlysinuria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02031354", 
            "org_study_id": "1308012508"
        }, 
        "intervention": {
            "arm_group_label": "Lysine Chloride", 
            "description": "Administration of 21g of lysine chloride (7g three times daily) for a period of time of 3 days", 
            "intervention_name": "Lysine Chloride", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Lysine Chloride", 
        "lastchanged_date": "April 16, 2014", 
        "location": {
            "contact": {
                "email": "olga.laur@yale.edu", 
                "last_name": "Olga Laur", 
                "phone": "404-723-6820"
            }, 
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06511"
                }, 
                "name": "Yale New Haven Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Prospective \"Pre-post\" Pilot Study on the Effects of Dietary Chloride Supplementation on Neurohormonal and Diuretic Function in Patients With Heart Failure", 
        "overall_contact": {
            "email": "olga.laur@yale.edu", 
            "last_name": "Olga Laur, BS", 
            "phone": "4047236820"
        }, 
        "overall_official": {
            "affiliation": "Yale University", 
            "last_name": "Jeffrey M Testani, MD/MTR", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in plasma renin activity following lysine chloride administration", 
                "safety_issue": "No", 
                "time_frame": "3 days"
            }, 
            {
                "measure": "Change in urinary renin level following lysine chloride administration", 
                "safety_issue": "No", 
                "time_frame": "3 days"
            }, 
            {
                "description": "Diuretic response will me evaluated by measuring volume of urine produced following diuretic administration", 
                "measure": "Change in diuretic response following lysine chloride administration", 
                "safety_issue": "No", 
                "time_frame": "3 days"
            }
        ], 
        "reference": [
            {
                "PMID": "12660669", 
                "citation": "Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J. 2003 Mar;145(3):459-66."
            }, 
            {
                "PMID": "31796", 
                "citation": "Kirchner KA, Kotchen TA, Galla JH, Luke RG. Importance of chloride for acute inhibition of renin by sodium chloride. Am J Physiol. 1978 Nov;235(5):F444-50."
            }, 
            {
                "PMID": "14439868", 
                "citation": "RUBIN AL, SPRITZ N, MEAD AW, HERRMANN RA, BRAVEMAN WS, LUCKEY EH. The use of L-lysine monomydrochloride in combination with mercurial diuretics in the treatment of refractory fluid retention. Circulation. 1960 Mar;21:332-6."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02031354"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yale University", 
            "investigator_full_name": "Jeffrey Testani", 
            "investigator_title": "Assistant Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Yale University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}